Müller, CEO SQS 6 6 6 0 _ 2 / J u n e 2 0 19 / V er si o n 2 .0 Swiss Association for Quality and Management Systems (SQS) Bernstrasse 103, 3052 Zollikofen, Switzerland A.

Müller, CEO SQS 6 6 6 0 _ 2 / J u n e 2 0 19 / V er si o n 2 .0 Swiss Association for Quality and Management Systems (SQS) Bernstrasse 103, 3052 Zollikofen, Switzerland A.

Müller, CEO SQS 6 6 6 0 _ 2 / J u n e 2 0 19 / V er si o n 2 .0 Swiss Association for Quality and Management Systems (SQS) Bernstrasse 103, 3052 Zollikofen, Switzerland A.

Yes, achieving this target will support Avient's achievement of Abs 2. Row 1 Scope 2, location-based We are reporting a Scope 2, location-based figure Scope 2, market-based We are reporting a Scope 2, market-based figure Comment C6.3 (C6.3) What were your organization’s gross global Scope 2 emissions in metric tons CO2e? Reporting year Scope 2, location-based 134,961 Scope 2, market-based (if applicable) 87,577 Comment C6.4 (C6.4) Are there any sources (e.g. facilities, specific GHGs, activities, geographies, etc.) of Scope 1 and Scope 2 emissions that are within your selected reporting boundary which are not included in your disclosure?

To prepare samples with an active ingredient, a linear low-density poly(ethylene) masterbatch “AMPE 143101” 2 ZANDER ET AL. Figure 2 shows the performance of a select series of Versaflex™ and OnFlex™ GLS™ TPEs with a range of ZPT additive (1000–3000 ppm). Inoguchi, IHS Markit; Specialty Chemicals Update Program 2020, 1, 10. [2] N.

Usually it is 2° for parallel walls, however non-parallel walls should be 1/2° . For t 2 /t 1 = 1, K = 1. The proper temperature profile can be seen in Chapter 2 .

Microsoft PowerPoint - Avient February IR Meetings AVIENT CORPORATION (NYSE: AVNT) F E B R U A R Y 1 7 - 1 8 , 2 0 2 1 I N V E S T O R M E E T I N G S H O S T E D B Y G O L D M A N S A C H S A N D M O R G A N S T A N L E Y D I S C L A I M E R 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 25 Capex / Revenue 2021E (%) AV I E N T I S A SS E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 6 2 3 4 4 5 5 5 6 6 6 7 9 25 A vi e n t A vi e n t (E xc l. SEGMENT HIGHLIGHTS U.S. & Canada 50% EMEA 26% Asia 16% Latin America 8% 2020 SEGMENT, END MARKET AND GEOGRAPHY 30 GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 21%Industrial 15% Wire & Cable 6% Building & Construction 6% Electrical & Electronics 4% END MARKET REVENUE Transportation 10% Healthcare 15% All data reflects 2020 Pro forma for acquisition of the Clariant Masterbatch business. (1) The total company sales and EBITDA of $3,783M and $457M, respectively, include intercompany sales eliminations and corporate costs $2,043M $331M $709M $124M $1,110M $70M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $457M$3,783M (1) Packaging 35% Consumer 23% Healthcare 8% Industrial 14% Building & Construction 8% Transportation 7% Wire & Cable 3% Electrical & Electronics 2% C O L O R , A D D I T I V E S & I N K S 2 0 2 0 P F R E V E N U E | $ 2 . 0 B I L L I O N US & Canada 31% EMEA 40% Asia 22% Latin America 7% END MARKET REGION 31 2020 figures Pro forma for acquisition of the Clariant Masterbatch business S P E C I A L T Y E N G I N E E R E D M A T E R I A L S Consumer 24% Healthcare 10% Packaging 6% Wire & Cable(1) 24% Electrical & Electronics 13% Transporation 11% Industrial 10% Building & Construction 2% 2 0 2 0 R E V E N U E | $ 7 0 9 M I L L I O N END MARKET US & Canada 58% EMEA 23% Asia 19% REGION 32 (1) Approximately 50% of Wire and Cable sales are associated with Fiber Optic Cabling D I S T R I B U T I O N 2 0 2 0 R E V E N U E | $ 1 . 1 B I L L I O N Healthcare 29% Consumer 25% Packaging 2% Industrial 20% Transportation 14% Electrical & Electronics 5% Building & Construction 4% Wire & Cable 1% US & Canada 82% Asia 3% Latin America 15% END MARKET REGION K E Y S U P P L I E R S 33 AMERICAS EMEA ASIA Consumer 26% Healthcare 19% Packaging 13% Industrial 16% Wire & Cable 7% Building & Construction 5% Electrical & Electronics 4% Packaging 34% Consumer 16%Healthcare 5% Industrial 17% Wire & Cable 10% Building & Construction 8% Electrical & Electronics 3% Packaging 32% Consumer 27% Healthcare 12% Industrial 6% Wire & Cable 6% Building & Construction 4% Electrical & Electronics 9% Transportation 10% Transportation 7% Transportation 4% 2020 figures Pro forma for acquisition of the Clariant Masterbatch business T O T A L C O M PA N Y R E G I O N A L S A L E S B Y E N D M A R K E T (58% of sales) (26% of sales) (16% of sales) 34 Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Garratt 2/08/2021 — — — — — 5,417 225,185 2/14/2022 — — — — — 4,794 199,287 2/17/2023 — — — — — 5,701 236,991 2/04/2015 9,200 — — 38.27 2/04/2025 — — 2/15/2017 13,250 — — 34.10 2/15/2027 — — 2/14/2018 11,050 — — 41.89 2/14/2028 — — 2/11/2019 18,200 — — 31.54 2/11/2029 — — 2/10/2020 19,650 — — 31.48 2/10/2030 — — 2/08/2021 13,433 6,717 — 42.27 2/08/2031 — — 2/14/2022 — — 16,000 52.64 2/14/2032 — — 2/17/2023 — — 18,800 42.93 2/17/2033 — — J.R. Rathbun 2/08/2021 — — — — — 5,417 225,185 2/14/2022 — — — — — 4,794 199,287 2/17/2023 — — — — — 7,036 292,487 2/4/2015 2,500 — — 38.27 2/4/2025 — — 2/10/2016 10,400 — — 24.98 2/10/2026 — — 2/15/2017 10,100 — — 34.10 2/15/2027 — — 2/14/2018 10,400 — — 41.89 2/14/2028 — — 2/11/2019 17,150 — — 31.54 2/11/2029 — — 2/10/2020 19,200 — — 31.48 2/10/2030 — — 2/08/2021 13,433 6,717 — 42.27 2/08/2031 — — 2/14/2022 — — 16,000 52.64 2/14/2032 — — 2/17/2023 — — 23,250 42.93 2/17/2033 — — L.K. Kunkle (3) 2/08/2021 — — — — — 5,792 240,773 2/14/2022 — — — — — 5,425 225,517 2/17/2023 — — — — — 6,470 268,958 2/15/2017 12,100 — — 34.10 2/15/2027 — — 2/14/2018 11,500 — — 41.89 2/14/2028 — — 2/11/2019 19,250 — — 31.54 2/11/2029 — — 2/10/2020 21,200 — — 31.48 2/10/2030 — — 2/08/2021 14,433 7,217 — 42.27 2/08/2031 — — 2/14/2022 — — 18,050 52.64 2/14/2032 — — 2/17/2023 — — 21,250 42.93 2/17/2033 — — R.M.

AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) N O V E M B E R 2 0 2 3 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. GUIDANCE $800 $754 Guidance Actual $128 $123 Guidance Actual Sales Adjusted EBITDA (in millions) $0.56 $0.57 Guidance Actual Adjusted EPS (in millions) 13 • Demand impacted by destocking and cautious customer sentiment • Positive net price benefit: o CAI - Pricing flat and raw material deflation o SEM - Pricing flat with unfavorable mix related to healthcare, more than offset with raw material deflation • Cost reductions driven by Clariant synergies and reduced administrative costs Q3 EBITDA BRIDGE ($ millions) CAI: Price / Mix -) Deflation 22) SEM: Price / Mix (6) Deflation 13) Net Price Benefit 29) Cost Reductions 13) Wage Inflation (8) FX 1) Q3 2023 Actual $ 123) Adjusted EBITDA Q3 2022 Pro Forma $ 137) Demand (49) 14 2 0 2 3 G U I D A N C E Q4 2023 GUIDANCE VS. Avient 2011, 2018 and 2021 multiples reflect trailing 12 months EBITDA at December 31. 28 EV / 2023E EBITDA 6.5 8.5 11.0 8.9 12.0 11.9 10.9 9.9 8.2 16.3 13.8 11.9 9.6 9.5 9.5 9.2 7.7 20 11 20 18 20 21 O ct 20 23 A V Y R P M P P G K W R FU L E C L H X L S C L A S H FM C C E H U N E M N Avient Historic Multiple Avient Specialty Formulators Other Specialty / Chemical Companies A P P E N D I X 30 Performance Additives 16% Pigments 12% TiO2 10% Dyestuffs 2% Polyethylene 11% Nylon 6% Polypropylene 5% Styrenic Block Copolymer 5% Other Raw Materials 33% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 2022 pro forma results for the acquisition of Avient Protective Materials RA W MATERIAL BASKET SEGMENT DATA U.S. & Canada 40% EMEA 37% Asia 18% Latin America 5% 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 20% Packaging 24% Industrial 15% Building and Construction 10% Telecommunications 4% Energy 4% Defense 6% END MARKET REVENUE $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M (1) Transportation 9% Healthcare 8% 32 (1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs 2 0 2 2 R E V E N U E | $ 2 . 4 B I L L I O N US & Canada 34% EMEA 38% Asia 20% Latin America 8% END MARKET REGION 33 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 2% COLOR, ADDITIVES & INKS 2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N US & Canada 52% EMEA 35% Asia 13% 34 Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% END MARKET REGION SPECIALTY ENGINEERED MATERIALS Packaging 32% Consumer 27% Healthcare 8% Industrial 14% Building & Construction 5% Telecommunications 3% Energy 1% Defense 1% Asia (18% of sales) Transportation 9% 2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S Packaging 27% Consumer 14% Healthcare 5% Industrial 17% Building & Construction 10% Energy 5% Defense 8% EMEA (37% of sales)Transportation 11% Packaging 13% Consumer 24% Healthcare 12% Industrial 15% Building & Construction 13% Energy 5% Defense 5% US & Canada (40% of sales) Transportation 7% Packaging 56% Consumer 23% Healthcare 4% Industrial 7% Building & Construction 4% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3% Telecommunications 6% 35 B Y E N D M A R K E T Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

AVIENT CORPORATION P R O F O R M A F I N A N C I A L S F O R D Y N E E M A A C Q U I S I T I O N A N D D I S T R I B U T I O N A S D I S C O N T I N U E D O P E R A T I O N S (NYSE: AVNT) S E P T E M B E R 2 7 , 2 0 2 2 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Additionally, Adjusted EPS excludes the impact of special items and amortization expense associated with intangible assets. 2 PRO FORMA 2021 TO 2022 BRIDGE 3 2021 EPS from Continuing Operations 1.69$ Pro Forma & Special Items 1.33 Proforma 2021 Adjusted EPS 3.02$ FX Impact (0.22) China Lockdowns / Russia Import Sales (0.24) Outdoor High Performance (0.13) Dyneema 0.06 Color, Additives and Inks 0.38 Legacy Specialty Engineered Materials 0.22 Other 0.01 Proforma 2022 Adjusted EPS 3.10$ Constant Currency Sales Sales COLOR, ADDITIVES AND INKS Q1 Q2 Q3 Q4 FY 4% Q1 Q2 Q3 Q4 FY 4% 7% (4%) (9%) 6% (10%) 0% 1% 2% Constant currency reflects prior year results restated at current year foreign exchange rates Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY 7% 10% 4% (3%) 12% (6%) 5% 6% 9% 610 650 624 649 587 565 581 526 2,402 2,390 589 650 589 649 543 565 545 526 2,266 2,390 116 121 112 119 93 95 88 79 409 414 113 121 106 119 87 95 84 79 390 414 Constant Currency EBITDA EBITDA 10% 4 Constant Currency EBITDA Sales Q1 Q2 Q3 Q4 FY (1%) PRO FORMA SPECIALTY ENGINEERED MATERIALS Q1 Q2 Q3 Q4 FY 16%8% (8%) (8%) 3% (6%) (6%) (2%) 2% EBITDA Constant Currency Sales Constant currency reflects prior year results restated at current year foreign exchange rates Q1 Q2 Q3 Q4 FY 4% Q1 Q2 Q3 Q4 FY 20%12% (1%) (2%) 5% (1%) (2%) 3% 6% 314 338 348 343 325 300 321 295 1,308 1,276 303 338 329 343 303 300 301 295 1,236 1,276 67 78 75 77 70 66 66 62 278 283 65 78 73 77 67 66 63 62 268 283 5 Constant Currency Adjusted EPS Adjusted EPS PRO FORMA AVIENT Q1 Q2 Q3 Q4 FY 10% (3%) (21%) 3% Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY 9% 5% 7% (5%) (9%) (1%) (1%) (12%) 1% Sales Constant Currency Sales Constant currency reflects prior year results restated at current year foreign exchange rates Q1 Q2 Q3 Q4 FY 17% 8% (14%) 11% Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY 14% 10% 11% 2% (3%) 5% 8% (5%) 7% EBITDA Constant Currency EBITDA 925 987 973 992 912 867 902 823 3,712 3,669 893 987 919 992 847 867 845 823 3,504 3,669 161 176 164 172 142 141 133 117 600 606 155 176 157 172 131 141 123 117 566 6068% 2% 0.84 0.98 0.87 0.96 0.70 0.68 0.61 0.48 3.02 3.10 0.79 0.98 0.82 0.96 0.63 0.68 0.56 0.48 2.80 3.10 17% 24% 6 Three Months Ended 2022年3月31日 Three Months Ended 2021年3月31日 Reconciliation to Condensed Consolidated Statements of Income Avient EPS Avient EPS Net income from continuing operations $ 64.7 $ 60.4 Net income attributable to noncontrolling interests (0.3) (0.4) Net income from continuing operations attributable to Avient shareholders $ 64.4 $ 0.70 $ 60.0 $ 0.65 Special items, after tax $ 6.4 $ 0.07 $ 2.6 $ 0.03 APM pro forma adjustments 2.6 0.03 (3.1) (0.03) Amortization expense, after tax 17.4 0.19 17.9 0.19 Adjusted pro forma net income / EPS $ 90.8 $ 0.98 $ 77.4 $ 0.84 Weighted average diluted shares 92.3 92.2 Three Months Ended 2022年6月30日 Three Months Ended 2021年6月30日 Reconciliation to Condensed Consolidated Statements of Income Avient EPS Avient EPS Net income from continuing operations $ 62.8 $ 50.2 Net income attributable to noncontrolling interests — (0.6) Net income from continuing operations attributable to Avient shareholders $ 62.8 $ 0.68 $ 49.6 $ 0.54 Special items, after tax $ 3.2 $ 0.03 $ 11.7 $ 0.13 APM pro forma adjustments 5.2 0.06 1.4 0.02 Amortization expense, after tax 17.2 0.19 17.8 0.19 Adjusted pro forma net income / EPS $ 88.4 $ 0.96 $ 80.5 $ 0.87 Weighted average diluted shares 92.1 92.4 Three Months Ended 2021年9月30日 Reconciliation to Condensed Consolidated Statements of Income Avient EPS Net income from continuing operations $ 33.4 Net income attributable to noncontrolling interests 0.3 Net income from continuing operations attributable to Avient shareholders $ 33.7 $ 0.37 Special items, after tax $ 11.7 $ 0.13 APM pro forma adjustments 1.5 0.02 Amortization expense, after tax 17.6 0.19 Adjusted pro forma net income / EPS $ 64.5 $ 0.70 Weighted average diluted shares 92.2 Adjusted EPS may not recalculate due to rounding. 1 Three Months Ended 2021年12月31日 Year Ended 2021年12月31日 Reconciliation to Condensed Consolidated Statements of Income Avient EPS Avient EPS Net income from continuing operations $ 11.2 $ 155.2 Net income attributable to noncontrolling interests 0.9 0.2 Net income from continuing operations attributable to Avient shareholders $ 12.1 $ 0.13 $ 155.4 $ 1.69 Special items, after tax $ 24.0 $ 0.26 $ 50.0 $ 0.54 APM pro forma adjustments 2.5 0.03 1.6 0.02 Amortization expense, after tax 17.8 0.19 71.1 0.77 Adjusted pro forma net income / EPS $ 56.4 $ 0.61 $ 278.1 $ 3.02 Weighted average diluted shares 92.4 92.1 Reconciliation of Color, Additives and Inks EBITDA Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022 Operating Income 88.8 86.3 66.8 61.2 303.1 94.5 93.6 Depreciation and amortization 27.4 25.3 26.6 26.4 105.7 26.0 25.9 EBITDA $ 116.2 $ 111.6 $ 93.4 $ 87.6 $ 408.8 $ 120.5 $ 119.5 Reconciliation of Specialty Engineered Materials EBITDA Q1 2021 Q2 2021 Q3 2021 SEM Pro forma APM Pro forma SEM SEM Pro forma APM Pro forma SEM SEM Pro forma APM Pro forma SEM Operating Income 32.6 9.1 41.7 35.8 13.9 49.7 30.0 15.2 45.2 Depreciation and amortization 7.8 17.5 25.3 8.1 17.3 25.4 7.9 17.1 25.0 EBITDA $ 40.4 $ 26.6 $ 67.0 $ 43.9 $ 31.2 $ 75.1 $ 37.9 $ 32.3 $ 70.2 Reconciliation of Specialty Engineered Materials EBITDA Q4 2021 YTD 2021 SEM Pro forma APM Pro forma SEM SEM Pro forma APM Pro forma SEM Operating Income 27.1 11.7 38.8 125.5 49.9 175.4 Depreciation and amortization 8.0 18.9 26.9 31.8 70.8 102.6 EBITDA $ 35.1 $ 30.6 $ 65.7 $ 157.3 $ 120.7 $ 278.0 2 Reconciliation of Specialty Engineered Materials EBITDA Q1 2022 Q2 2022 SEM Pro forma APM Pro forma SEM SEM Pro forma APM Pro forma SEM Operating Income 38.3 15.4 53.7 35.2 17.7 52.9 Depreciation and amortization 7.8 16.6 24.4 7.7 16.6 24.3 EBITDA $ 46.1 $ 32.0 $ 78.1 $ 42.9 $ 34.3 $ 77.2 Reconciliation of Avient consolidated pro forma EBITDA Q1 2021 Q2 2021 Q3 2021 Avient Pro forma APM Pro forma Avient Avient Pro forma APM Pro forma Avient Avient Pro forma APM Pro forma Avient Net income from continuing operations 60.4 (3.1) 57.3 50.2 1.4 51.6 33.4 1.5 34.9 Income tax expense 16.3 1.1 17.4 13.8 1.3 15.1 2.0 2.5 4.5 Interest expense 19.3 11.1 30.4 19.5 11.2 30.7 19.0 11.2 30.2 Depreciation and amortization 36.9 17.5 54.4 33.6 17.3 50.9 36.6 17.1 53.7 EBITDA 132.9 26.6 159.5 117.1 31.2 148.3 91.0 32.3 123.3 Special items, before tax 2.4 — 2.4 14.2 — 14.2 19.9 — 19.9 Depreciation included in special items (0.6) — (0.6) 1.4 — 1.4 (0.9) — (0.9) Adjusted EBITDA $ 134.7 $ 26.6 $ 161.3 $ 132.7 $ 31.2 $ 163.9 $ 110.0 $ 32.3 $ 142.3 Reconciliation of Avient consolidated pro forma EBITDA Q4 2021 YTD 2021 Avient Pro forma APM Pro forma Avient Avient Pro forma APM Pro forma Avient Net income from continuing operations 11.2 2.5 13.7 155.2 1.6 156.8 Income tax expense 16.2 (1.9) 14.3 48.3 3.7 52.0 Interest expense 17.5 11.1 28.6 75.3 44.6 119.9 Depreciation and amortization 37.9 18.9 56.8 145.0 70.8 215.8 EBITDA 82.8 30.6 113.4 423.8 120.7 544.5 Special items, before tax 20.6 — 20.6 57.1 — 57.1 Depreciation included in special items (1.6) — (1.6) (1.7) — (1.7) Adjusted EBITDA $ 101.8 $ 30.6 $ 132.4 $ 479.2 $ 120.7 $ 599.9 3 Reconciliation of Avient consolidated pro forma EBITDA Q1 2022 Q2 2022 Avient Pro forma APM Pro forma Avient Avient Pro forma APM Pro forma Avient Net income from continuing operations 64.7 2.6 67.3 62.8 5.2 68.0 Income tax expense 20.0 1.7 21.7 22.7 1.4 24.1 Interest expense 16.9 11.1 28.0 16.2 11.1 27.3 Depreciation and amortization 37.6 16.6 54.2 36.3 16.6 52.9 EBITDA 139.2 32.0 171.2 138.0 34.3 172.3 Special items, before tax 6.6 — 6.6 0.9 — 0.9 Depreciation included in special items (2.1) — (2.1) (1.1) — (1.1) Adjusted EBITDA $ 143.7 $ 32.0 $ 175.7 $ 137.8 $ 34.3 $ 172.1 Reconciliation of Specialty Engineered Pro Forma Sales Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022 Sales 214.7 238.9 231.7 226.3 911.6 243.1 242.3 Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5 Pro forma sales $ 313.6 $ 347.7 $ 325.5 $ 321.2 $ 1,308.0 $ 337.9 $ 342.8 Reconciliation of Avient Pro Forma Sales Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022 Sales 826.0 864.5 818.0 807.1 3,315.6 892.2 891.0 Pro forma APM 98.9 108.8 93.8 94.9 396.4 94.8 100.5 Pro forma sales $ 924.9 $ 973.3 $ 911.8 $ 902.0 $ 3,712.0 $ 987.0 $ 991.5 4 IR Slides V17 - 9.26 324pm IR Deck - AVNT-2022.09.27 Pre Release v2